Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jan 25:5:7.
doi: 10.21037/acr-20-108. eCollection 2021.

Roles of specific drug therapies for severe pulmonary arterial hypertension in palliative care: a case report

Chi Yan Wong  1 , Kwok Wai Tsang  1 , Cho Wing Li  1 , Ho Yan Au  1 , Kwok Ying Chan  1
Affiliations
Case Reports

Roles of specific drug therapies for severe pulmonary arterial hypertension in palliative care: a case report

Chi Yan Wong et al. AME Case Rep. .

Abstract

Pulmonary arterial hypertension (PAH) is an uncommon but potentially life-threatening illness. The elevated pulmonary arterial blood pressure will lead to right heart failure and even cardiopulmonary collapse if it is severe. Apart from general supportive measures, pulmonary hypertension-specific therapies (PHST) are available to slow down disease progression, but they are not curative. According to previous studies, many patients with severe PAH often had significant physical symptoms and psychological distress for both themselves and their families at the end of life. Moreover, they would have repeated admissions due to physical deterioration and decline in functioning associated with worsening in cardiac function. Some of these patients might suffer from unnecessary aggressive interventions and resuscitation because of lack of advance care planning discussion. As such, Palliative Care (PC) would be an important element as part of the overall management. Hereby, we reported a patient with severe PAH and schizoaffective disorder achieved good outcome from the use of combination PHST and PC input. Her physical and psychosocial needs could be addressed well by PC team. This case report showed the collaborative work between PC and parent teams. While parent team was able to manage the medical conditions related to PAH, however the physical and psychosocial needs should be addressed by PC team. More importantly, the PC team has essential roles of providing advance care planning discussions with the patient and help to reduce unnecessary interventions. Furthermore, PC would coordinate the community service to support her while staying at home. Roles of PHST will also be discussed in this case. Clinicians must take into account possible hemodynamic effects of any palliative intervention for PAH.

Keywords: Pulmonary hypertension; palliative care (PC); selexipag.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/acr-20-108). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Computed Tomography (CT) thorax shows enlarged right ventricle with prominent pulmonary trunk.
Figure 2
Figure 2
Chest X-ray shows congested lung field and prominent right hilum.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Klinger JR, Elliot CG, Levine DJ, et al. Therapy for pulmonary arterial hypertension in adults: Update of the CHEST guidelines and expert panel report. Chest 2019;155:565-86. 10.1016/j.chest.2018.11.030 - DOI - PubMed
    1. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC) European Respiratory Society (ERS) ; International Society of Heart and Lung Transplantation (ISHLT), et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:1219-63. 10.1183/09031936.00139009 - DOI - PubMed
    1. Benza RL, Miller DP, Barst RJ, et al. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest 2012;142:448-56. 10.1378/chest.11-1460 - DOI - PubMed
    1. Galiè N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148-57. 10.1056/NEJMoa050010 - DOI - PubMed
    1. Pulido T, Adzerikho I, Channick RN, et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med 2013;369:809-18. 10.1056/NEJMoa1213917 - DOI - PubMed

Publication types